Award
Delivery Order #SPE2DR26FMEM8
Delivery Order for Keytruda by DMS Pharmaceutical Group under Pharmaceutical Procurement IDV
Buyer
Defense Logistics Agency
Award Amount
$186,742.22
Ceiling
$186,742.22
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 23, 2026
Identifier
SPE2DR26FMEM8
NAICS
424210
This award represents a delivery order under a multi-year indefinite delivery vehicle (IDV) contract managed by DMS Pharmaceutical Group Inc., a healthcare solutions provider specializing in pharmaceutical distribution. The contract involves the procurement of Keytruda 100 MG/4 ML vials, a significant oncology drug used for cancer treatment, ensuring essential medication availability within government healthcare facilities. The scope of work includes the timely delivery of this pharmaceutical product to the designated location in Park Ridge, Illinois, supporting ongoing medical therapies. This delivery order is part of a competitive and structured procurement process upheld by the existing IDV, highlighting its importance in maintaining a reliable supply chain for critical medications. The performance period is brief and specific, scheduled for a targeted timeframe within March 2026, reflecting demand-driven distribution under the prevailing contract vehicle.
Description
4571140595!KEYTRUDA 100 MG/4 ML VIAL 4ML